Daily non-political popular news in brief.

Cetuximab may prolong survival for head and neck cancer patients

Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.

Read more »

Keywords: cetuximab, prolong, survival, head, neck, cancer, patients, patient

« Previous | Next »

Similar news on "Cetuximab may prolong survival for head and neck cancer patients":

1. Cetuximab with radiotherapy does not increase side effects for head and neck cancer patients
   01-18-2007 · EurekAlert!
   The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
   Similar news · Read more »
   
2. Study examines factors associated with survival in advanced laryngeal cancer
   12-17-2007 · EurekAlert!
   Type of treatment, sex, race and insurance status are associated with survival rates among patients with advanced laryngeal cancer, according to a report in the December issue of Archives of Otolaryngology -- Head & Neck Surgery, one of the JAMA/Archives journals.
   Similar news · Read more »
   
3. Penn researchers find emotional well-being has no influence on cancer survival
   10-22-2007 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine have found that emotional well-being is not an independent factor affecting the prognosis of patients with head and neck cancers. This study appears in the Dec. 1 issue of CANCER.
   Similar news · Read more »
   
4. Intravenous chemoradiation effective for inoperable head, neck cancer; easier for patients, doctors
   11-06-2006 · EurekAlert!
   Chemoradiation (radiation and chemotherapy given at the same time) given through a needle or tube inserted into a vein (intravenous) is as effective as treatment given directly to the tumor through a tube inserted into an artery (intra-arterial) for patients with inoperable head and neck cancer, according to a randomized study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
   Similar news · Read more »
   
5. Decrease in the use of radiotherapy procedures for the treatment of cancer in hospitals
   10-09-2007 · EurekAlert!
   The study is based on data of patients, treated in any of the 10 Andalusian public hospitals for one year, who were submitted to radiotherapy procedures for the treatment of tumours in the breast, lung, head and neck, cervix and endometrium.
   Similar news · Read more »
   
6. Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
   11-03-2006 · EurekAlert!
   There is new hope for some of the most seriously ill colon cancer patients today, following the release of a consensus statement by 72 leading oncology surgeons from 14 countries, including the United States. The Peritoneal Surface Malignancy Group (PSMG) has concluded that surgery, followed by heated chemotherapy delivered through the lower abdomen of the patient before leaving the operating room, may significantly increase the life expectancy for patients with Stage IV colorectal cancer.
   Similar news · Read more »
   
7. Study shows zinc doesn't help head and neck cancer patients
   04-02-2007 · EurekAlert!
   Zinc sulfate, a supplement thought to be helpful in regaining the sense of taste for some head and neck cancer patients after radiation therapy, has been found to have no significant impact on preventing or curing taste alteration, according to a study released today in the International Journal for Radiation Oncology, Biology, Physics, the official journal of ASTRO.
   Similar news · Read more »
   
8. Cetuximab increases survival in advanced colorectal cancer patients, study shows
   04-16-2007 · EurekAlert!
   Research presented today at the 2007 Annual Meeting of the American Association for Cancer Research confirmed that there is now an effective treatment option for colorectal cancer patients for whom all other treatment options have been exhausted -- cetuximab.
   Similar news · Read more »
   
9. Study identifies patients' reasons for quitting jobs after treatment for head and neck cancer
   05-21-2007 · EurekAlert!
   After treatment, 38.1 percent of patients with head and neck cancer who were employed at the time of cancer diagnosis reported discontinuing work because of their cancer and treatment, according to a report in the May issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.
   Similar news · Read more »
   
10. Research shows survival benefit for leukemia patients treated with arsenic trioxide
    06-04-2007 · EurekAlert!
    Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
    Similar news · Read more »